MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0057517 UTJZBNWKVJEERL-BKTRWHITSA-N | CL(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:0) (2S)-3-{[(2R)-2,3-bis[(9Z)-hexadec-9-enoyloxy]propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy((2R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-2-(octadecanoyloxy)propoxy)phosphinic acid 1'-[1,2-Di(9Z-hexadecenoyl)-rac-glycero-3-phospho],3'-[1,2-di(5Z,8Z,11Z,14Z-eicosatetraenoyl)-rac-glycero-3-phospho]-glycerol 1'-[1,2-Dipalmitoleoyl-rac-glycero-3-phospho],3'-[1,2-diarachidonoyl-rac-glycero-3-phospho]-glycerol CL(1'-[16:1(9Z)/16:1(9Z)],3'-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)]) CL(16:1/16:1/20:4/20:4) CL(72:10) Cardiolipin(16:1/16:1/20:4/20:4) Cardiolipin(72:10) [(2S)-3-({[(2R)-2,3-bis[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid |
SLM:000536875 slm:000536875 UTJZBNWKVJEERL-AGJWDODCSA-L | Cardiolipin (16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:0) 1'-[1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phospho],3'-[1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-octadecanoyl-sn-glycero-3-phospho]-glycerol CL (16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:0) |
hmdb:HMDB57517 | secondary/obsolete/fantasy identifier |